Olfactory Impairment and Mortality

alexandrossfakianakis shared this article with you from Inoreader Olfactory Impairment and Mortality via JAMA Otolaryngology–Head & Neck Surgery Current Issue The COVID-19 pandemic has elevated the world's attention to olfactory impairment (OI). As a cardinal symptom of the many early variants of the SARS-CoV-2 virus, we have never seen such global attention toward one of our most important senses. Although the prevalence of OI has increased dramatically with COVID-19, OIs have long been a significant health concern. Prior to the COVID-19 pandemic, the median length of time from onset of OI to evaluation by a clinician was 13 months, with many individuals waiting up to 3 years before seeking evaluation. During that time, patients did not receive treatment or counseling, compounding the potential associations of OI with patient health. View on Web

Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.